Eliasson, B., Smith, U., Mullen, S., Cushman, S. W., Sherman, A. S., & Yang, J. (2014). Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patients. Adipocyte.

Eliasson, Bjorn, Ulf Smith, Shawn Mullen, Samuel W. Cushman, Arthur S. Sherman, and Jian Yang. "Amelioration of Insulin Resistance By Rosiglitazone Is Associated With Increased Adipose Cell Size in Obese Type 2 Diabetic Patients." Adipocyte 2014.

Eliasson, Bjorn, et al. "Amelioration of Insulin Resistance By Rosiglitazone Is Associated With Increased Adipose Cell Size in Obese Type 2 Diabetic Patients." Adipocyte 2014.